Vanta Bioscience Q4 Results

  • BSE: 540729
  • NSE: -
  • ISIN: INE695X01011
  • Sector: Biotechnology & Drugs
BSE
47.322.16 (4.78%)
Volume750.00
Updated: Tue 26 Nov, 2024 | 14:39:17
NSE
This stock is not traded on NSE
Today: 47.32
47.32
52-Wk: 37.01
101.64

Q4 Results Highlights

  • Total Income
    ₹3.55 Cr.
    -
  • Operating Profit
    ₹-3.70 Cr.
    -
  • Profit After Tax
    ₹-1.77 Cr.
    -
  • Operating Margin
    -104.45%
    (NA%)
Note: Comparison is on YoY basis

Quarterly - Vanta Bioscience Q4 Results

*All figures in crores except per share values
Fiscal PeriodMar 24-QoQ CompMar 23YoY Comp
Total Revenue 3.55--%3.45-%
Selling/ General/ Admin Expenses Total 2.10--%2.81-%
Depreciation/ Amortization 2.95--%1.36-%
Other Operating Expenses Total 2.26--%1.95-%
Total Operating Expense 7.25--%6.66-%
Operating Income -3.70--%-3.21-%
Net Income Before Taxes -6.53--%-5.93-%
Net Income -1.77--%-3.92-%
Diluted Normalized EPS -2.82--%-6.21-%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts